This Dataverse contains data generated by the "Resiliency through Azithromycin for Children (REACH) Côte d’Ivoire: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d’Ivoire" study. REACH Côte d’Ivoire is funded by the ACCELERATE Project, through Sightsavers Inc., and led by FHI 360 in collaboration with four key partners: Côte d’Ivoire National Neglected Tropical Disease program, the National Nutrition Program, Institute Pasteur of Côte d’Ivoire and the Directorate of Information Technology and Health. The aim of the study is to generate evidence to understand what is required to bring bi-annual, mass drug administration (MDA) of single-dose azithromycin for children ages 1 to 11 months in high child mortality settings to scale using the existing MDA platform used for trachoma and other public health interventions.
Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

1 to 2 of 2 Results
Community-level Monitoring of Antimicrobial Resistance following Mass Administration of Azithromycin to Reduce Child Mortality in Côte d’Ivoire: Results from Two Rounds of Surveillance
Jun 24, 2025
Nelson, Felicity; Dulli, Lisa, 2025, "Community-level Monitoring of Antimicrobial Resistance following Mass Administration of Azithromycin to Reduce Child Mortality in Côte d’Ivoire: Results from Two Rounds of Surveillance", https://doi.org/10.7910/DVN/9BAA5H, Harvard Dataverse, V1
This dataset contains data documentation and datasets from the REACH project's first two rounds of community-based antimicrobial resistance surveillance studies conducted in Côte d’Ivoire. The objective of this study was to assess the effect of Mass Drug Administration (MDA) of azithromycin in community-level bacterial resistance to azithromycin am...
REACH Côte d’Ivoire: Feasibility and Acceptability of Integrating Mass Distribution of Azithromycin to Children 1-11 Months into a Trachoma Mass Drug Administration Campaign to Reduce Child Mortality
REACH Côte d’Ivoire: Feasibility and Acceptability of Integrating Mass Distribution of Azithromycin to Children 1-11 Months into a Trachoma Mass Drug Administration Campaign to Reduce Child Mortality
Jun 13, 2024
Murray, Katherine; Dulli, Lisa, 2024, "REACH Côte d’Ivoire: Feasibility and Acceptability of Integrating Mass Distribution of Azithromycin to Children 1-11 Months into a Trachoma Mass Drug Administration Campaign to Reduce Child Mortality", https://doi.org/10.7910/DVN/PC0ZKS, Harvard Dataverse, V1
This dataset contains data documentation and datasets from the REACH Côte d’Ivoire feasibility and acceptability study. The aim of this pilot study was to examine the operational feasibility and acceptability of leveraging the existing trachoma MDA platform to expand delivery of single-dose azithromycin during a trachoma MDA campaign to children 1...
Add Data

Sign up or log in to create a dataverse or add a dataset.

Sign Up Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.